ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,172Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 1278

$803K Total Retail Price of All Prescriptions

Rank: 29 out of 1278

711 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 711 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 711 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 853 758 1 2
SIMVASTATIN 437 376 2 3
LISINOPRIL 370 328 3 1
METFORMIN HCL 352 303 4 4
OMEPRAZOLE 311 251 5 6
ZOLPIDEM TARTRATE 187 158 6 16
ATENOLOL 177 174 7 11
FUROSEMIDE 171 165 8 10
CRESTOR 168 168 9 31
HYDROCHLOROTHIAZIDE 166 134 10 8
FLUTICASONE PROPIONATE 165 142 11 24
HYDROCODONE-ACETAMINOPHEN 165 132 S3 11 7
POTASSIUM CHLORIDE 158 146 13 21
METOPROLOL TARTRATE 151 127 14 9
FLUOXETINE HCL 121 75 15 41
CELEBREX 110 95 16 87
LOSARTAN POTASSIUM 110 110 16 19
GABAPENTIN 105 82 18 12
WARFARIN SODIUM 102 99 19 17
ALLOPURINOL 102 98 19 36
MORPHINE SULFATE ER 98 39 S2 21 42
AMLODIPINE BESYLATE 97 90 22 5
CIPROFLOXACIN HCL 95 83 23 53
NEXIUM 92 66 24 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 70 24 30
SERTRALINE HCL 91 72 26 28
TAMSULOSIN HCL 84 82 27 32
METOPROLOL SUCCINATE 84 84 27 23
TERAZOSIN HCL 83 72 29 59
JANUVIA 82 74 30 68
ALENDRONATE SODIUM 81 78 31 18
LOVASTATIN 80 80 32 13
SPIRIVA 75 75 33 65
BUPROPION XL 72 49 34 184
CLOPIDOGREL 72 69 34 45
ATORVASTATIN CALCIUM 69 62 36 15
VERAPAMIL ER 68 68 37 84
FENOFIBRATE 68 51 37 47
VESICARE 66 59 39 174
OXYCODONE-ACETAMINOPHEN 65 37 S2 40 29
SYMBICORT 63 50 41 164
SYNTHROID 60 58 42 63
ETODOLAC 59 54 43 158
FINASTERIDE 57 43 44 82
ESTRADIOL 55 46 R 45 71
BYSTOLIC 55 52 45 136
TRAZODONE HCL 53 42 47 38
RANITIDINE HCL 53 48 47 20
NAMENDA 51 49 49 77
ONGLYZA 51 50 49 224
CARVEDILOL 51 51 49 39
OXYCODONE HCL 50 17 S2 52 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.